Provided by Tiger Fintech (Singapore) Pte. Ltd.

Denali Therapeutics Inc.

13.95
-0.0400-0.29%
Post-market: 13.950.00000.00%16:46 EDT
Volume:2.21M
Turnover:31.36M
Market Cap:2.03B
PE:-5.22
High:14.66
Open:14.49
Low:13.83
Close:13.99
Loading ...
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 10, 2024

Major Issues Report

Form 8-K - Current report
Sep 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities